#63: The Psychedelic Renaissance - Rick Doblin, PhD
The FitMind Podcast: Mental Fitness, Neuroscience & Psychology
00:00
The Rise of for Profit Companies Focusing on Psychedelics
In the past, when I started maps in 86, there was no hope for investors. The FDA didn't really start opening the door for years later. There are now three companies listed on the stock market that have a market cap of $1.5 billion. For-profit work with psychedelics is coming from new companies that have just been set up to focus in this area.
Transcript
Play full episode
